Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 61, Issue suppl 1, Pages S25-S31
Publisher
Oxford University Press (OUP)
Online
2015-07-29
DOI
10.1093/cid/civ427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
- (2015) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis
- (2015) Tawanda Gumbo et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
- (2015) Tawanda Gumbo et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
- (2014) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy
- (2014) Tawanda Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The pyrazinamide susceptibility breakpoint above which combination therapy fails
- (2014) T. Gumbo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
- (2014) Keertan Dheda et al. Lancet Respiratory Medicine
- A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients
- (2013) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Global Transcriptional Profiling of Longitudinal Clinical Isolates of Mycobacterium tuberculosis Exhibiting Rapid Accumulation of Drug Resistance
- (2013) Anirvan Chatterjee et al. PLoS One
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
- (2012) Diana Machado et al. PLoS One
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis
- (2011) Guy E. Thwaites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium tuberculosis but to Better Antimicrobial Effect: a New Paradigm for Antituberculosis Drug Scheduling
- (2011) Shashikant Srivastava et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience
- (2011) A. D. Pranger et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
- (2011) D. A. Williamson et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin
- (2011) Sylvain Goutelle et al. JOURNAL OF THEORETICAL BIOLOGY
- Limited-Sampling Strategies for Therapeutic Drug Monitoring of Moxifloxacin in Patients With Tuberculosis
- (2011) Arianna D Pranger et al. THERAPEUTIC DRUG MONITORING
- Effect of Administration of Moxifloxacin plus Rifampin against Mycobacterium tuberculosis for 7 of 7 Days versus 5 of 7 Days in an In Vitro Pharmacodynamic System
- (2011) G. L. Drusano et al. mBio
- In SilicoChildren and the Glass Mouse Model: Clinical Trial Simulations To Identify and Individualize Optimal Isoniazid Doses in Children with Tuberculosis
- (2010) Prakash M. Jeena et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
- (2010) T. Gumbo ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of Ethambutol
- (2010) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fiber Infection Model
- (2010) G. L. Drusano et al. mBio
- Fluoroquinolone Resistance inMycobacterium tuberculosis
- (2009) Rose A. Devasia et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
- (2009) S. Goutelle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?
- (2009) K. C. Chang et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs
- (2008) G.R. Davies et al. TUBERCULOSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More